Havyco Vy & Tea 45g

Official notice

25 Mar 2022

Last checked

25 Mar 2022

Medium riskACCC

An official ACCC notice concerns Havyco Vy & Tea 45g. The use of undeclared substances may be harmful. Sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. The product can be dangerous when used with other medications. Phenolphthalein was withdrawn from sale in many markets in the late 1990s due to concerns it may cause an increased risk of cancer with long term use. Published 2022-03-25.

What to do now

Consumers should immediately stop using this product and return all remaining products to the place of purchase for a full refund. For further information, contact Vy & Tea Australia by phone on 03 9703 1010, by email at vyteaaustralia@gmail.com or visit the TGA website at https://apps.TGA.gov.au/Prod/sara/arn-detail.aspx k=RC-2022-RN-00275-1

Recall number

f8483717-f32f-44af-bbf8-2afa29c77582

Official notice

2022-03-25

The hazard

The use of undeclared substances may be harmful. Sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. The product can be dangerous when used with other medications. Phenolphthalein was withdrawn from sale in many markets in the late 1990s due to concerns it may cause an increased risk of cancer with long term use.

Checked manually this time?

The app alerts you when a new official recall is published — no searching, no checking back.

Turn on recall alerts

Affected products

Product 1

Havyco Vy & Tea 45g Expiry dates: 01/06/2022 and 01/10/2022 Barcode: 8936125432063

Risk / hazard

The use of undeclared substances may be harmful. Sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. The product can be dangerous when used with other medications. Phenolphthalein was withdrawn from sale in many markets in the late 1990s due to concerns it may cause an increased risk of cancer with long term use.

Where it was sold

The source does not list specific retailers. See the official notice for where affected products were sold.

Location 1

AU · Australia

Affected area 1

AU · Australia

Source & status

Source

Tier

beta

Category

HOME

Classification

Pharmacy and medical products

App estimate

medium

Recall details

Recall number

f8483717-f32f-44af-bbf8-2afa29c77582

Classification

Pharmacy and medical products

Source tier

beta

Documents, notices & source

See the official notice and source documents for full details.

View full official notice
Something wrong on this page?

Weekly recall digest

Get next week's recalls before you need them.

One email every Monday — official-source recalls for your country, and nothing else. Unsubscribe from any email.

The digest is the slow lane — one email a week. For instant, severity-gated alerts the moment a notice is published, get the app.

This recall was published 25 Mar 2022. The next one won't wait for you to search.

RecallScope watches official sources for the brands and VINs you follow, and alerts you the moment a new notice is published.